Neoadjuvant Chemotherapy Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab
Conditions: Neoadjuvant Chemotherapy; Resectable Pancreatic Cancer Interventions: Drug: irinotecan liposome + oxaliplatin + 5-FU / LV; Drug: Adebellizumab Sponsors: Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO ®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany
Conditions: Resectable Non-small Cell Lung Cancer Interventions: Drug: Neoadjuvant nivolumab in combination with platinum-based chemotherapy Sponsors: Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC
Conditions: Stereotactic Radiotherapy; Immunotherapy; Breast Cancer Interventions: Drug: adebrelimab plus stereotactic radiotherapy followed by adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin); Drug: adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin) Sponsors: Shengjing Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma:A Prospective, Multicenter, Phase II Study
Conditions: Esophageal Squamous Cell Carcinoma; Neoadjuvant Therapies Interventions: Drug: Cardenilimab Combined With Chemotherapy Sponsors: Li Zhang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma; Neoadjuvant Therapies Interventions: Drug: Cardenilimab Combined With Chemotherapy Sponsors: Li Zhang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study
Conditions: Breast Cancer Interventions: Drug: Tucatinib; Drug: Trastuzumab; Drug: Pertuzumab Sponsors: The Netherlands Cancer Institute; Seagen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer
Conditions: Organoids; Breast Cancer; Neoadjuvant Chemotherapy Interventions: Procedure: Biopsy Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma
Conditions: Locally Advanced Hypopharyngeal Carcinoma Interventions: Drug: three cycles (toripalimab + cetuximab + platinum); Procedure: Radical surgery; Radiation: Radiotherapy or chemoradiotherapy Sponsors: Eye& ENT Hospital of Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Muscle Parameters and Pathological Response in Breast Cancer Patients
Conditions: Neoadjuvant Chemotherapy Interventions: Other: Neoadjuvant therapy Sponsors: Ac ıbadem Atunizade Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Micrometastases in Axillary Lymph Nodes in Breast Cancer, Post-neoadjuvant Chemotherapy
Conditions: Micrometastases; Neoadjuvant Chemotherapy Interventions: Procedure: Sentinel lymph node biopsy, axillary lymph node dissection Sponsors: Gangnam Severance Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
Response to Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced Oral Cancer
Conditions: Oral Cancer Interventions: Drug: PD-1 inhibitor+carboplatin+albumin-bound paclitaxel Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Neoadjuvant Pyrotinib Versus Placebo Combined With Chemotherapy in HR-positive and HER2-low Early Breast Cancer
Conditions: Breast Cancer Invasive; Hormone-receptor-positive Breast Cancer; HER2 Low Breast Carcinoma; Early-stage Breast Cancer Interventions: Drug: Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel; Drug: Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy
Conditions: Locally Advanced Pancreatic Adenocarcinoma; Stage III Pancreatic Cancer American Joint Committee on Cancer v8; Unresectable Pancreatic Adenocarcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Distal Pancreatectomy; Procedure: Laparoscopy; Procedure: Magnetic Resonance Imaging; Procedure: Pancreaticoduodenectomy; Other: Questionnaire Administration; Procedure: Surgical Procedure; Procedure: Total Pancreatectomy Sponsors: University of Southern California; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?
Conditions: Sentinel Lymph Node Interventions: Procedure: sentinle lymphnode biopsy Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant Chemotherapy
Conditions: Inflammatory Breast Cancer Interventions: Procedure: Breast conserving surgery; Procedure: Radical modified mastectomy Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials